Tower Research Capital LLC (Trc) Centessa Pharmaceuticals PLC Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,911 shares of CNTA stock, worth $107,982. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,911
Previous 479
716.49%
Holding current value
$107,982
Previous $6,000
1466.67%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CNTA
# of Institutions
139Shares Held
125MCall Options Held
1.49MPut Options Held
787K-
Medicxi Ventures Management (Jersey) LTD20MShares$551 Million73.31% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.8MShares$298 Million3.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10MShares$277 Million0.41% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$275 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$267 Million8.3% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...